We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 973

Landmark ruling on right to sue for invasion of privacy awaited

  • Squire Patton Boggs
  • -
  • Canada
  • -
  • October 6 2014

The courts in Ontario are being asked to rule on whether patients whose medical records have been improperly accessed by the hospital holding the data

Applications for leave to appeal dismissed

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 2 2014

On appeal from the judgment of the Court of Appeal for Quebec pronounced March 10, 2014. In 2002 and 2003, the Fédération des médecins spécialistes

Canadian online pharmacy enjoined from selling Indian generics to US customers

  • Norton Rose Fulbright LLP
  • -
  • Canada
  • -
  • October 2 2014

Global Pharmacy Canada (“GPC”) is an online prescription drug retailer that sells drugs sourced in India to customers in the United States. GPC is

Dow prevails over Nova in polymer patent suit

  • Smart & Biggar/Fetherstonhaugh
  • -
  • Canada
  • -
  • October 8 2014

The Dow Chemical Company (“Dow”) has prevailed in a Canadian patent infringement suit against Nova Chemicals Corporation (“Nova”) relating to Nova’s

Privacy law litigation in Ontario - from the bank to the hospital and beyond

  • Davis LLP
  • -
  • Canada
  • -
  • September 22 2014

Health information is generally regarded as among the most sensitive of personal information. Even members of the Millennial Generation, who

Markush claims can pose a risk of patent invalidity

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 28 2011

As patent law in Canada continues to evolve in significant ways, it is important to remind ourselves of cases from the past few years that continue to impact patent drafting today and to influence the validity of patents, especially pharmaceutical patents in Canada

Teva v Pfizer, or the “Viagra saga”: if there is no quid proper disclosure there can be no quo exclusive monopoly rights

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada
  • -
  • November 19 2012

Sildenafil is the active ingredient in Viagra, the blockbuster potency-enhancing drug marketed by Pfizer

FCA denies Apotex's claim for brand name's profits

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 20 2011

On December 16, 2011, the Federal Court of Appeal released a decision denying Apotex's claim for the profits of a brand name company

Plaintiff’s right to videorecord independent medical examinations andor to have a nominee present

  • Field Law
  • -
  • Canada
  • -
  • February 21 2013

The plaintiff sued for personal injury as a result of a motor vehicle accident that occurred on 14 November, 2007. The plaintiff alleged injuries to

Methods of medical treatment and dosage claims

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 28 2011

In Canada, claims to methods of medical treatment are considered to fall outside the definition of invention according to section 2 of the Patent Act and a decision of the Supreme Court of Canada